New research finds a new strategy for treating a deadly cancer by combining existing drugs to indirectly weaken tumor growth, ...
A study shows that high levels of negatively charged lipids can lock growth receptors into an overactive state, driving ...
CStone Pharmaceuticals ('CStone,' HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
EO1001 demonstrates up to ~40-fold greater potency than osimertinib in EGFR ECD-mutant tumor models EO4426 (tezacitabine) demonstrates selective targeting of DNA replication machinery and resistance ...
A new case report was published in Volume 13 of Oncoscience on March 11, 2026, titled “Erosive pustular dermatosis–like scalp ...
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; ...
A study designed to investigate why lung cancer incidence has increased among younger nonsmokers over the past few decades ...
NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) for improving outcomes for cancer patients, today announced that two poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results